Acadia Healthcare Company, Inc. (ACHC) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Acadia Healthcare Company’s revenue went from $2.8B in fiscal 2016 to $3.3B in fiscal 2025, growth of about 1.8% a year.
Net income in fiscal 2025 was -$1.1B, a net margin of -33.3%; the best year in this period was 2022 with $273M.
Over the twelve months to September 30, 2026, revenue was $3.4B and net income -$1.1B.
Free cash flow was -$440M in fiscal 2025 and positive in 8 of the 10 years shown.
The diluted share count rose 6% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.4B | $3.3B | $3.2B | $2.9B | $2.6B | $2.3B | $2.1B | $2.0B | $1.9B | $2.8B | $2.8B |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | -$1.1B | -$1.1B | $342M | -$25M | $374M | $276M | $184M | $586M | $594M | $604M | $609M |
| Net income | -$1.1B | -$1.1B | $256M | -$22M | $273M | $191M | -$672M | $109M | -$176M | $200M | $6M |
| EPS (diluted) | $-12.43 | $-12.16 | $2.78 | $-0.24 | $2.98 | $2.10 | $-7.59 | $1.24 | $-2.01 | $2.30 | $0.07 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +5.0% | +7.7% | +12.2% | +12.8% | +10.7% | +4.1% | +5.4% | −32.9% | +0.9% | +53.6% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $235M | $132M | $130M | $462M | $381M | $374M | $659M | $333M | $414M | $400M | $361M |
| Capital spending | -$259M | -$572M | -$690M | -$424M | -$296M | -$245M | -$225M | -$233M | -$253M | -$274M | -$307M |
| Free cash flow | -$24M | -$440M | -$561M | $38M | $84M | $130M | $434M | $100M | $161M | $125M | $54M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | $50M | — | — | — | — | — | — | — | — | — |
| Stock-based pay | $35M | $32M | $37M | $32M | $30M | $38M | $23M | $17M | $22M | $23M | $28M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $133M | $76M | $100M | $98M | $134M | $379M | $100M | $51M | $67M | $57M |
| Debt | — | $2.6B | $2.1B | $1.5B | $1.5B | $1.6B | $3.2B | $3.7B | $3.2B | $3.2B | $3.3B |
| Equity | — | $1.9B | $3.1B | $2.8B | $2.8B | $2.5B | $1.9B | $2.5B | $2.3B | $2.6B | $2.2B |
| Total assets | — | $5.5B | $6.0B | $5.4B | $5.0B | $4.8B | $6.5B | $6.9B | $6.2B | $6.4B | $6.0B |
| Shares (diluted) | 92M | 91M | 92M | 91M | 92M | 91M | 89M | 88M | 87M | 87M | 86M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | -31.7% | -32.2% | 10.8% | -0.9% | 14.3% | 11.9% | 8.8% | 29.2% | 31.2% | 21.3% | 21.6% |
| Net margin | -33.1% | -33.3% | 8.1% | -0.7% | 10.5% | 8.2% | -32.2% | 5.4% | -9.2% | 7.0% | 0.2% |
| FCF margin | -0.7% | -13.3% | -17.8% | 1.3% | 3.2% | 5.6% | 20.8% | 5.0% | 8.5% | 4.4% | 1.9% |
| ROIC | — | -18.3% | 5.1% | -0.4% | 6.5% | 5.0% | 2.8% | 6.4% | 9.2% | 8.8% | 8.8% |
| ROE | — | -56.6% | 8.3% | -0.8% | 9.7% | 7.6% | -35.4% | 4.3% | -7.5% | 7.8% | 0.3% |
Frequently asked questions
What is Acadia Healthcare Company’s annual revenue?
$3.3B in fiscal 2025 and $3.4B over the twelve months to September 30, 2026.
How much profit does Acadia Healthcare Company make?
Net income was -$1.1B in fiscal 2025 (net margin -33.3%).
Is Acadia Healthcare Company’s revenue growing?
Yes: revenue rose 5.0% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.